Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: KOSDAQ
  • Sector: Technology
  • Industry: Hardware
  • Sub-Industry: Electronics Components

Green Cross Cell Corp

+ Add to Watchlist

031390:KS

29,300 KRW 200 0.68%

As of 19:44:39 ET on 02/01/2015.

Snapshot for Green Cross Cell Corp (031390)

Open: 29,600 Day's Range: 29,100 - 29,700 Volume: 21,302
Previous Close: 29,500 52wk Range: 19,100 - 44,800 1-Yr Rtn: +31.84%

Stock Chart for 031390

No chart data available.
  • 031390:KS 29,350
  • 1D
  • 1M
  • 1Y
29,500
Interactive 031390 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 031390

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. KOSPI -
Earnings Per Share (KRW) (ttm) -242.8700
Est. EPS (KRW) (12/2014) -4.9900
Est. PEG Ratio -
Market Cap (M KRW) 343,860.61
Shares Outstanding (M) 11.70
30 Day Average Volume 110,637
Price/Book (mrq) 8.6006
Price/Sale (ttm) 10.8720
Dividend Indicated Gross Yield -%
Cash Dividend (KRW) -
Dividend Ex-Date 03/21/2003
5 Year Dividend Growth -
Next Earnings Announcement 02/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 031390

  • Revenue
  • Net Income (M/KRW)
  • Profit Margin (%)

Company Profile & Key Executives for 031390

Innocell Corp. is a biotechnology company. The Company develops and commercializes bio-products for immunity cell therapy, and operates autologous lymphocyte, cord blood, and tumor cell bank. Innocell also tests extreme drug resistance assay (EDR).

Han Sang-HeungCEO/Rep DirectorChoe Jong-SeongVice President
Lee Chang-HuiExecutive DirectorAn Jong-SeongExecutive Director
More Company Profile & Key Executives for 031390

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil